Camac Fund, LP
SEC CIK 1516478 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | Member of 10% owner group | 1.79M | $365.4K | — | 3 | 2022-08-17 | 2022-09-28 |
Most active insiders at KTTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | STEINMAN LAWRENCE | Dir | $100.0K | — |
| 2 | Coastlands Capital LP | 10% | $53.0K | — |
| 3 | Dumesnil Simon | Dir | $25.0K | — |
| 4 | Marques Tiago | CEO, Dir | $25.0K | — |
| 5 | Leahy Emer | Dir | — | — |
| 6 | Schneiderman Daniel H | CFO | — | — |
Camac Fund, LP made no open-market trades at KTTA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-30 | 2022-09-28+ | KTTA | Pasithea Therapeutics Corp. | Camac Fund, LP | Member of 10% owner group | P - Purchase | $1.19 | +64.4K | 1.79M | +4% | +$76.4K |
| MI | 2022-09-06 | 2022-09-01+ | KTTA | Pasithea Therapeutics Corp. | Camac Fund, LP | Member of 10% owner group | P - Purchase | $1.13 | +88.9K | 1.70M | +6% | +$100.6K |
| I | 2022-08-18 | 2022-08-17 | KTTA | Pasithea Therapeutics Corp. | Camac Fund, LP | Member of 10% owner group | P - Purchase | $1.21 | +155.8K | 1.61M | +11% | +$188.5K |
Purchase Sale Sale after option exercise All abbreviations